Marinus Pharmaceuticals reported 1.17M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
ALKERMES ALKS:US 55.16M 1.48M
Amgen AMGN:US $ 1561M 157M
Biogen BIIB:US $ 753.9M 93.8M
Eisai 4523:JP Y 50738M 6516M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Gilead Sciences GILD:US $ 1424M 1203M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Intra Cellular Therapies ITCI:US $ 3.16M 0.62M
Neurocrine Biosciences NBIX:US $ 4.6M 0.5M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Supernus Pharmaceuticals SUPN:US $ 17.93M 0.94M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M
YTE INCY:US $ 37.21M 1.36M